Primary gut aspergillosis in a patient with acute myeloid leukaemia: the importance of early suspicion and definitive treatment

Elizabeth Li*, Hayder Hussein, Adil Todiwala, Robert Kirby

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Aspergillus infection is a known complication in immunocompromised patients, particularly in those with impaired neutrophil function. The pathophysiology of respiratory tract infection and disseminated disease are well understood, and guidelines exist for early detection and treatment. The gut has been speculated to be the potential portal of entry for Aspergillus, though previous case series outline that this is often discovered late and results in high morbidity and mortality. Early clinical suspicion, with definitive surgical intervention and antifungal treatment with voriconazole, can significantly increase the chances of survival. In this article, the authors discuss a case of primary gut aspergillosis with secondary dissemination in a patient with acute myeloid leukaemia who developed serious sequelae.

Original languageEnglish
Article numberbcr2013202316
JournalBMJ case reports
Volume2014
DOIs
Publication statusPublished - 18 Mar 2014

Keywords

  • Antifungal Agents/therapeutic use
  • Aspergillosis/complications
  • Brain Diseases/complications
  • Humans
  • Intestinal Diseases/complications
  • Intestinal Obstruction/etiology
  • Leukemia, Myeloid, Acute/complications
  • Male
  • Middle Aged
  • Stroke/etiology

Fingerprint

Dive into the research topics of 'Primary gut aspergillosis in a patient with acute myeloid leukaemia: the importance of early suspicion and definitive treatment'. Together they form a unique fingerprint.

Cite this